Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 6/2013

01-07-2013 | Original Paper

We Can Do More Than Just Sell the Test: Pharmacist Perspectives About Over-the-Counter Rapid HIV Tests

Authors: Beth E. Meyerson, Priscilla T. Ryder, Christiana von Hippel, Kelsey Coy

Published in: AIDS and Behavior | Issue 6/2013

Login to get access

Abstract

Pharmacist attitudes about the over-the-counter (OTC) sale of HIV rapid tests in pharmacies were explored through interviews conducted among 17 licensed community pharmacists in a Midwestern, moderate HIV incidence state between May and September 2012. Participants recognized that OTC rapid HIV tests would increase the number of people aware of their HIV status. Concerns included linkage to care and results consultation for those who test HIV-positive. Point of sale was identified as an opportunity for consultation about the test and to establish a relationship for future discussion about results and linkage to care. Pharmacists could provide initial test consultation or information, and consultation about the test results in order to provide post diagnosis support and facilitate linkage to care.
Literature
1.
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedCrossRef
2.
3.
U.S. Centers for Disease Control and Prevention. Late HIV Testing—34 States, 1996-2005. MMWR 2009; 58(24), 661-665.
4.
5.
U.S. Centers for Disease Control and Prevention. Vital Signs: HIV Prevention Through Care and Treatment- United States. MMWR. 2011; 60(47):1618-1623.
6.
Gardner EM, McLees MP, Steiner JF, del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800.PubMedCrossRef
7.
Meyerson BE, Ryder PT, Smith C. Achieving pharmacy based public health: call for public health engagement. Public Health Reports. 2013;128(3):May/June.
8.
Agomo C. The role of community pharmacists in public health: a scoping review of the literature. J Pharmaceutical Health Services Research. 2012;3:25–33.CrossRef
9.
Abramowitz PW. The evolution and metamorphosis of the pharmacy practice model. AM J Health System Pharmacy. 2009;66:1437–46.CrossRef
10.
Hogue MD, Grabenstein JD, Foster SL, Rothholz MC. Pharmacist involvement with immunizations: a decade of professional advancement. J Am Pharm Assoc (Wash DC). 2006;46:168–82.
11.
Weitzel KW, Goode JV. Implementation of a pharmacy-based immunization program in a supermarket chain. J Am Pharm Assoc (Wash). 2000;40:252–6.
12.
Grabenstein JD. Pharmacists as vaccine advocates: roles in community pharmacies, nursing homes and hospitals. Vaccine. 1998;16(18):1705–10.PubMedCrossRef
13.
Chandra A, Malcolm N, Fetters M. Practicing health promotion through pharmacy counseling activities. Health Promot Pract. 2003;4:64–71.PubMedCrossRef
14.
Letassy N, Dennis V, Lyons TJ, et al. Know your diabetes risk project: student pharmacists educating adults about diabetes risk in a community pharmacy setting. J Am Pharm Assoc. 2010;50:188–94.CrossRef
15.
Patwardhan PD, Chewning BA. Effectiveness of intervention to implement tobacco cessation counseling in community chain pharmacies. J Am Pharm Assoc. 2012;52:507–14.CrossRef
16.
Elias MN, Burden AM, Cadarette SM. The impact of pharmacist interventions on osteoporosis management: a systematic review. Osteoporosis In. 2011;22(10):2587–96.CrossRef
17.
Murphy P, Cocohoba J, Tang A, Pietrandoni G, Hou J, Guglielmo B. Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. AIDS Patient Care and STDs. 2012;26(9):526–31.PubMedCrossRef
18.
Hirsch JD, Rosenquist A, Best BM, Miller TA, Gilmer TP. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for medi-cal beneficiaries. J Manag Care Pharmacy. 2009;15(1):32–41.
19.
Bunting BA, Smith BH, Rutherford SE. The Ashville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc. 2008;48(1):23–31.CrossRef
20.
Yuksel N, Majumdar SR, Biggs C, Tsuyuki RT. Community pharmacist initiated screening and patient education program for osteoporosis: randomized controlled trial. Osteoporos In. 2010;21:391–8.CrossRef
21.
Amesty S, Blaney S, Crawford ND, Rivera AV, Fuller C. Pharmacy staff characteristics associated with support for pharmacy-based HIV testing. AIDS Patient Care and STDs. 2012;26(9):526–31. doi:10.​1089/​apc.​2012.​0189.CrossRef
22.
Lutnik A, Case P, Kral AH. Injection Drug Users’ Perspectives on Placing HIV Prevention and other clinical services in pharmacy settings. J Urb Health Bull NY Acad Med. 2012;89(2):354–64.CrossRef
23.
Ryder PT, Meyerson BE, Coy KC, Von Hippel CD. (in review) Rapid HIV Testing in Community Pharmacies: Perspectives from Community Pharmacists.
Metadata
Title
We Can Do More Than Just Sell the Test: Pharmacist Perspectives About Over-the-Counter Rapid HIV Tests
Authors
Beth E. Meyerson
Priscilla T. Ryder
Christiana von Hippel
Kelsey Coy
Publication date
01-07-2013
Publisher
Springer US
Published in
AIDS and Behavior / Issue 6/2013
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0427-y

Other articles of this Issue 6/2013

AIDS and Behavior 6/2013 Go to the issue

Original Paper

Enhancing Acceptability and Use of Sexual Barrier Products Among HIV Concordant and Discordant Couples

Brief Report

Feasibility of Interactive Text message Response (ITR) as a Novel, Real-Time Measure of Adherence to Antiretroviral Therapy for HIV+ Youth

Original Paper

A Randomized Controlled Trial to Evaluate the Relative Efficacy of the Addition of a Psycho-Social Intervention to Standard-of-Care Services in Reducing Attrition and Improving Attendance Among First-Time Users of Methadone Maintenance Treatment in China

Original Paper

The Importance of Measuring and Accounting for Potential Biases in Respondent-Driven Samples

Substantive Review

An International Systematic Review and Meta-analysis of Multisession Psychosocial Interventions Compared with Educational or Minimal Interventions on the HIV Sex Risk Behaviors of People Who Use Drugs

Original Paper

Theory, Measurement and Hard Times: Some Issues for HIV/AIDS Research
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits